Resistance to EGFR blockade in colorectal cancer: liquid biopsies and latent subclones.
Cell Res
| Authors | |
| Keywords | |
| Abstract | Two recent papers identify KRAS activation as a mechanism of acquired resistance to EGFR blockade in colorectal cancer. In doing so, they suggest that resistance to single-agent EGFR blockade will be unavoidable because these alterations exist as latent subclones within the tumor even prior to the initiation of therapy. |
| Year of Publication | 2013
|
| Journal | Cell Res
|
| Volume | 23
|
| Issue | 1
|
| Pages | 13-4
|
| Date Published | 2013 Jan
|
| ISSN | 1748-7838
|
| URL | |
| DOI | 10.1038/cr.2012.115
|
| PubMed ID | 22847744
|
| PubMed Central ID | PMC3541651
|
| Links | |
| Grant list | T32 GM007753 / GM / NIGMS NIH HHS / United States
|